Keytruda
Generic Name: PembrolizumabPembrolizumab is used to treat cancer.
May Treat: EGFR negative, ALK negative, non-small cell lung cancer · HER2-neg gastric or GE junction adenocarcinoma · HER2-positive gastric adenocarcinoma · Hodgkin's lymphoma · Merkel cell carcinoma and more
Drug Class: Antineoplastic-Anti-Programmed Cell Death Receptor-1 (PD-1) MC Antib.
Availability: Prescription Required
Pregnancy: Consult your doctor. This medication may be harmful to an unborn child.
Lactation: This drug should not be given to breastfeeding mothers
Alcohol: Limit intake while taking this medication
Driving: May cause drowsiness or dizziness. Use caution
Manufacturer: MERCK SHARP & D
PrecautionsFor informational purposes only. Consult a medical professional for advice.
Source: First Databank Learn more
- People also ask
Pembrolizumab - Wikipedia
Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. It is administered by slow intravenous injection.
Wikipedia · Text under CC-BY-SA license- Estimated Reading Time: 10 mins
Keytruda (pembrolizumab): Side effects, uses, cost, and more
- The FDA has approved Keytruda to treat melanoma (a type of skin cancer) in adults and certain children. Specifically, Keytruda is approved to treat melanoma that either: 1. cannot be surgically removed or 2. has become metastatic (has spread to other parts of the body) The FDA has also approved Keytruda to help prevent melanoma from coming back in ...
- Estimated Reading Time: 9 mins
KEYTRUDA® (pembrolizumab) and LENVIMA® …
Learn about how KEYTRUDA® (pembrolizumab) and LENVIMA® (lenvatinib) are used as a combination treatment for certain types of cancer.
Keytruda: 7 things you should know - Drugs.com
- 4.6/10(224)
- Estimated Reading Time: 8 mins
- How it works. Keytruda is a brand (trade) name for pembrolizumab which is a type of …
- Upsides. Keytruda) is approved to treat many different types of cancer in adults and …
- Downsides. If you are between the ages of 18 and 60, take no other medication or have no …
- Bottom Line. Keytruda is a type of immunotherapy that helps boost the immune system's …
- Tips. Keytruda can uncommonly cause your immune system to attack healthy organs and …
KEYTRUDA® (pembrolizumab) | Indications and …
KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line treatment of patients with metastatic nonsquamous non–small cell lung cancer (NSCLC), with no epidermal growth factor receptor …
The Keytruda Story - Science | AAAS
Jul 27, 2017 · Most big drugs have a tangled history, and this one is certainly not going to break tradition. As witness: It was discovered accidentally, by biotech scientists looking for drugs that …
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Adult …
May 25, 2017 · KEYTRUDA, as a single agent, is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 …
Keytruda | European Medicines Agency (EMA)
Jul 30, 2015 · Keytruda, in combination with chemotherapy with or without bevacizumab, is indicated for the treatment of persistent, recurrent, or metastatic cervical cancer in adults …
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus …
Oct 13, 2021 · KEYTRUDA, in combination with chemotherapy, is indicated for the treatment of patients with locally recurrent unresectable or metastatic TNBC whose tumors express PD-L1 …
